title: Pharmacokinetic and safety of raltegravir in pregnancy.
authors.forename: Leonardo
authors.initials: L
authors.lastname: Croci
authors.forename: Michele
authors.initials: M
authors.lastname: Trezzi
authors.forename: Maria Pia
authors.initials: MP
authors.lastname: Allegri
authors.forename: Tiziana
authors.initials: T
authors.lastname: Carli
authors.forename: Silvia
authors.initials: S
authors.lastname: Chigiotti
authors.forename: Maria Piera
authors.initials: MP
authors.lastname: Riccardi
authors.forename: Barbara
authors.initials: B
authors.lastname: Ricciardi
authors.forename: Mario
authors.initials: M
authors.lastname: Toti
authors.forename: Cesira
authors.initials: C
authors.lastname: Nencioni
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D024921:Drug Resistance, Multiple, Viral; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D033261:Maternal-Fetal Relations / Q000187:drug effects*; D011247:Pregnancy; D011760:Pyrrolidinones / Q000009:adverse effects* / Q000493:pharmacokinetics*; D000068898:Raltegravir Potassium; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium